What's impacting the Wesfarmers share price on Thursday?

A change of management of an important business has put Wesfarmers in focus.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Wesfarmers shares are slightly in the green today 
  • There is a new leader of the Australian Pharmaceutical Industries (API) business 
  • Wesfarmers is attracted to the long-term attributes of the healthcare sector 

The Wesfarmers Ltd (ASX: WES) share price is currently in the green amid news that Australian Pharmaceutical Industries (API) has a new boss.

Wesfarmers shares are up around 0.1% and the S&P/ASX 200 Index (ASX: XJO) is also up around 0.1%.

Wesfarmers Health is the new division of the company which will be the home of businesses within the space of health, beauty and wellbeing.

According to reporting by the Australian Financial Review, Wesfarmers Health boss Emily Amos is now in charge of running API after Richard Vincent stepped down.

Vincent has reportedly decided to move into an advisory role, so Wesfarmers Health will still be able to benefit from this.

API was the first move by Wesfarmers into the health sector, but Wesfarmers leader Rob Scott said that it will look at any further acquisitions through a "consumer lens" according to the AFR. Beauty and skincare products, as well as digital health, could be areas of interest.

Over time, this segment could have a growing influence on the Wesfarmers share price.

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls

Image source: Getty Images

What are some of the positives of moving into healthcare?

Wesfarmers is attracted to healthcare because it's "an important, large sector with long-term growth tailwinds". From 2019-2020 to 2060-61, the population aged 65 and over will double to 8.9 million.

The company says that there is increasing demand for health, beauty and wellbeing products and services. Wesfarmers noted that customers are becoming more interested in health and wellness. There is also increased focus on preventative health measures and treatments.

Management believes that 'data and digital' can transform the customer journey in healthcare. There are "opportunities to leverage technology to improve health outcomes".

Wesfarmers stated:

With strong fundamentals and the ability to leverage group capabilities, Wesfarmers Health can deliver superior returns over the long-term.

In terms of the API business, there are three segments. There's the pharmacy distribution segment which is one of only four national full-line pharmaceutical wholesalers. Priceline is another segment, which is a leading network of franchised pharmacies and retail stores. Clear Skincare Clinics has a growing footprint in the fragmented and "high growth" non-surgical aesthetics market. It also has an expanding range of high margin own label products.

Wesfarmers share price snapshot

Over the past month, Wesfarmers shares have risen by around 8%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A group of three young men sit on a sofa in a home environment with a bowl of popcorn and beer bottles in front of them cheering on one of their teams on a phone.
Consumer Staples & Discretionary Shares

Guess which ASX stock is closing in on its multi-year high

Tabcorp shares are back near their highs after a strong 12-month run.

Read more »

Woman with headphones on relaxing and looking at her phone happily.
Consumer Staples & Discretionary Shares

Morgans just initiated coverage on this consumer discretionary stock with a buy rating

This newly listed ASX stock has strong upside, according to Morgans.

Read more »

Three women laughing and enjoying their gambling winnings while sitting at a poker machine.
Consumer Staples & Discretionary Shares

Down 20%, are these ASX gaming stocks ready to surge?

If sentiment stabilises, these ASX shares could bounce back up to 65%.

Read more »

A family sits on their couch, eyes glued to the television.
Consumer Staples & Discretionary Shares

Consumer discretionary shares to target for a long-term rebound

These stocks are all trading below fair value.

Read more »

A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.
Consumer Staples & Discretionary Shares

Should you buy the dip on A2 Milk shares today?

Here’s the latest price target for beaten down A2 Milk shares from Citi.

Read more »

CEO leading a board meeting.
Consumer Staples & Discretionary Shares

This ASX retail stock is sliding after a surprise leadership announcement

Universal shares slip after a surprise CEO handover adds fresh uncertainty.

Read more »

Woman with a concerned look on her face holding a credit card and smartphone.
Consumer Staples & Discretionary Shares

Why are A2 Milk shares sinking 18% today?

Let's see why investors are selling off this stock on Monday.

Read more »

A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.
Consumer Staples & Discretionary Shares

The a2 Milk Company lowers FY26 guidance amid supply chain challenges

a2 Milk Company sees strong demand but trims FY26 guidance on supply disruptions.

Read more »